http://elpais.com
スペインの医療費削減のために健康保険制度から排除される弱症状の426の薬についての3人の家庭医者の意見
Algunos obsoletos, otros muy útiles
Tres médicos de familia opinan sobre la lista de medicamentos que Sanidad dejará de financiar
Creen que con una mejor gestión se ahorraría más
Some outdated, some very useful
Three family physicians think about the list of drugs that will stop financing health
They believe that better management would save more
Health will bring 456 drugs in public funding
DOCUMENT: Drugs that have no public funding
Experts warn that more expensive drugs replace the excluded
Victor Lopez Madrid 27 JUN 2012 - 20:11 CET
Three family physicians think about the list of drugs that will stop financing health
They believe that better management would save more
Health will bring 456 drugs in public funding
DOCUMENT: Drugs that have no public funding
Experts warn that more expensive drugs replace the excluded
Victor Lopez Madrid 27 JUN 2012 - 20:11 CET
It is true that many of the 456 drugs that are excluded from public funding are obsolete, or have limited clinical value. But it is also true that some of them are useful, and are often prescribed in health centers across the country. That's what I think three family physicians consulted by this newspaper after news yesterday afternoon the list of drugs that will no longer be subsidized. The measure proposed by Health generally not affect the patients, but it can harm certain groups such as the chronically ill. And all criticize the absolute lack of information. There has been no information from the Ministry of Health nor has agreed with the medical groups. A complaint that the directors have repeated today in the Basque Country, Andalusia and Catalonia before the meeting of the Inter-Territorial Council of Health who have had the Autonomous Communities with the Minister of Health, Ana Mato.
"I think many of these drugs should not be funded," said José María Molero, family doctor. "From some of them, such as artificial tears, it has become over zealous. Others have no proven therapeutic benefit. " But qualifies: "Yes there are drugs that do not meet this criterion of low utility. For example, antacids, or some antiinflamatarios topics that are used for conditions such as osteoarthritis. There may now have to be replaced by other treatments that will be more expensive. "
"It affects the health of my patients, but its economy," says a family doctor
That coincides with another family physician, Salvador Tranche, expressing concern that "are going to recall drugs cheaper, but will have to be replaced by newer, but also more expensive, thus saving the event will to hell. " And not everything that is removed from the funding is obsolete. "Acyclovir is widely used, and its usefulness is demonstrated. Or drugs like Almax for people with gastrointestinal problems. "
Another practitioner, Miguel Angel Hernandez, also notes that it believes useful drugs "mucolytics for patients with COPD (chronic obstructive pulmonary disease), anti-inflammatories, antacids ...". Hernandez himself generally valued positively as the Ministry of Health, because he believes that most drugs will lose public funding have little clinical utility.
Beyond what specific drugs should be withdrawn or not, criticism is also directed to the opportunity of a measure like this. "My opinion is that you should evaluate all drugs, not just these," said Miguel Angel Hernandez. "The administration would have to assess a more global to include many more things, such as hospital treatment, prostheses, coronary treatments ... We could achieve more savings in the list of drugs we are talking now."
"What worries me is that this measure is more of the same. It should go beyond the cut, closing schools, lower the wages of professionals. Would have to take management measures be really useful, "says Salvador Tranche. And he points to a reality for many patients in this crisis: "There are people who tell you you can not buy the drugs they prescribe because you have no money, unemployed families, or who need treatment we reduce them because they can not cover for a long time. It is possible that the withdrawal of funding for these drugs will not affect the health of my patients, but its economy. "
"I think many of these drugs should not be funded," said José María Molero, family doctor. "From some of them, such as artificial tears, it has become over zealous. Others have no proven therapeutic benefit. " But qualifies: "Yes there are drugs that do not meet this criterion of low utility. For example, antacids, or some antiinflamatarios topics that are used for conditions such as osteoarthritis. There may now have to be replaced by other treatments that will be more expensive. "
"It affects the health of my patients, but its economy," says a family doctor
That coincides with another family physician, Salvador Tranche, expressing concern that "are going to recall drugs cheaper, but will have to be replaced by newer, but also more expensive, thus saving the event will to hell. " And not everything that is removed from the funding is obsolete. "Acyclovir is widely used, and its usefulness is demonstrated. Or drugs like Almax for people with gastrointestinal problems. "
Another practitioner, Miguel Angel Hernandez, also notes that it believes useful drugs "mucolytics for patients with COPD (chronic obstructive pulmonary disease), anti-inflammatories, antacids ...". Hernandez himself generally valued positively as the Ministry of Health, because he believes that most drugs will lose public funding have little clinical utility.
Beyond what specific drugs should be withdrawn or not, criticism is also directed to the opportunity of a measure like this. "My opinion is that you should evaluate all drugs, not just these," said Miguel Angel Hernandez. "The administration would have to assess a more global to include many more things, such as hospital treatment, prostheses, coronary treatments ... We could achieve more savings in the list of drugs we are talking now."
"What worries me is that this measure is more of the same. It should go beyond the cut, closing schools, lower the wages of professionals. Would have to take management measures be really useful, "says Salvador Tranche. And he points to a reality for many patients in this crisis: "There are people who tell you you can not buy the drugs they prescribe because you have no money, unemployed families, or who need treatment we reduce them because they can not cover for a long time. It is possible that the withdrawal of funding for these drugs will not affect the health of my patients, but its economy. "
0 件のコメント:
コメントを投稿